Alexander Lauten

Showing 1-8 of 8 articles

Interventions for valvular disease

Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

Dreger H, Mattig I, Hewing B, Knebel F, Lauten A, Lembcke A, Thoenes M, Roehle R, Stangl V, Landmesser U, Grubitzsch H, Stangl K, Laule M, Schöbel C, Baumann G

January 14, 2020 | 10.4244/EIJ-D-19-00901

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou C, Özdemir R, Pfister R, Bergmann M, Bartunek J, Kilic T, Lauten A, Schmeisser A, Zoghi M, Anker S, Sievert H, Mahfoud F

August 29, 2019 | 10.4244/EIJ-D-19-00342

The Experts “Live” Workshop of the EuroCTO Club 2017, Berlin

Bufe A, Di Mario C, Landmesser U, Gessner M, Sianos G, Garbo R, Dini C, Lauer B, Boudou N, Grancini L, Avran A, Lauten A, Mashayekhi K, Hildick-Smith D, Escaned J, Buettner H, Reifart N, Lapp H, Galassi A, Werner G

April 20, 2018 | 10.4244/EIJV13I17A324

Interventions for heart failure

PERKAT RV: first in vivo data of a novel right heart assist device

Kretzschmar D, Lauten A, Schubert H, Bischoff S, Schulze PC, Ferrari M

April 6, 2018 | 10.4244/EIJ-D-17-00899

Interventions for valvular disease

Impact of concomitant mitral regurgitation on transvalvular gradient and flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis

Katte F, Franz M, Jung C, Figulla H, Leistner D, Jakob P, Stahli B, Kretzschmar D, Lauten A, Figulla H

February 20, 2018 | 10.4244/EIJ-D-17-00476

Interventions for valvular disease

Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve

Figulla H, Kiss K, Lauten A

September 18, 2016 | 10.4244/EIJV12SYA32

Interventions for valvular disease

Tricuspid valve interventions in 2015

Lauten A, Figulla HR

September 17, 2015 | 10.4244/EIJV11SWA37

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

1

Latest news

Challenging TAVI anatomies, risk prediction for PCI of CTOs, antithrombotic strategies, and more

NEW ahead of print: FFR and myocardial mass

Post atrioventricular (AV) branch intervention coronary angiogram

CTO Percutaneous Coronary Intervention Scores: Present and Future

Evangelia Vemmou

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Cardiocerebral Continuum in Cognitive Function After TAVI

This week’s JAA’s: Coronary Bifurcation in Asia Pacific, 3year outcomes: Compare-ACUTE...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke